≡
選單
Goodinfo!
台灣股市資訊網
股票一覽 
 

4157 太景*-KY / 融資融券(季)

4157 太景*-KY

日期: 11/09權證標的
成交價昨收漲跌價漲跌幅振幅開盤最高最低
8.137.81+0.32+4.1%5.51%7.868.297.86
成交張數成交金額成交筆數成交均張成交均價PBRPERPEG
574468.4萬3421.68張/筆8.165.6536.950.23
昨日張數昨日金額昨日筆數昨日均張昨日均價昨漲跌價 (幅)
1,5691,198萬6432.44張/筆7.64-0.08 (-1.01%)

連續漲跌: 連2跌→漲  ( +0.32元 / +4.1%)

財報評分: 最新68分 / 平均61分

上櫃指數: 321.97 (17.95 / +5.9%)

新聞及公告

• 更正2026年7月至9月資金貸與他人申報資訊 (公告訊息 11/03 15:28)

• 更正公告太景*-KY越南合作夥伴遞交太捷信(奈諾沙星)口服膠囊及靜脈輸液新藥上市許可申請(NDA)，並獲越南藥品管理局 (DAV)正式受理相關資訊。(更正第5點遞件合作夥伴公司名稱) (公告訊息 10/19 14:18)

• 太景*-KY接獲越南合作夥伴Fideschem Inc.通知已遞交太捷信(奈諾沙星)口服膠囊及靜脈輸液新藥上市許可申請(NDA) ，並獲越南藥品管理局（DAV）正式受理。 (公告訊息 10/18 14:52)

• 〈台股盤後〉國慶連假前觀望賣壓沉重 終場跌492點失守5日線 (Anue鉅亨 10/08 14:55)

• 8檔防疫股鎖漲停！　流感危機狂吸搶短買盤 (ETtoday新聞雲 10/08 12:37)

• 太景*-KY董事會通過2026年第二季合併財報 (公告訊息 08/26 17:35)

• 代重要子公司太景醫藥研發(北京)有限公司公告監事異動 (公告訊息 08/26 15:05)

• 代重要子公司太景生物科技股份有限公司公告法人代表人董事異動 (公告訊息 08/26 15:01)

• 2026年第2季財務報告董事會召開日期為2026年08月26日 (公告訊息 08/18 19:10)

• 接獲合作夥伴Boryung Biopharma Co.Ltd.通知抗流感病毒新藥 Pixavir marboxil (TG-1000)膠囊獲韓國食品藥物安全部(MFDS)同意進行三期臨床試驗。 (公告訊息 08/10 15:38)

• 太景*-KY法人代表人董事異動 (公告訊息 07/31 16:30)

• 代重要子公司太景生物科技股份有限公司公告法人代表人董事辭任 (公告訊息 07/27 17:15)

• 太景*-KY法人代表人董事辭任 (公告訊息 07/27 17:01)

• 太景*-KY取得會計師2025年內部控制專案審查報告 (公告訊息 06/26 14:24)

4157 太景*-KY 資券餘額(季)

日線｜周線｜月線｜季線｜年線｜

融資融券統計

 11/09 資券狀況2026年統計資料
買進賣出現償增減餘額使用
率		連增連減資券
互抵		資券
當沖		券資比年初
餘額		增減
張數		增減
率		最高
張數		最低
張數
融資14220-88,1774.59%增→2減00%0.09%
增→無
6,629+1,548+23.4%8,946
(07/06)		6,517
(01/07)
融券000070%增→無48-41-85.4%93
(01/08)		0
(03/20)

資券累計增減統計

2日
11/06
~11/09
3日
11/05
~11/09
5日
11/03
~11/09
10日
10/27
~11/09
1個月
10/12
~11/09
3個月
08/11
~11/09
半年
05/12
~11/09
1年
'25/11/10
~11/09
3年
'23/11/13
~11/09
10年
融資增減(張)
(增減幅)		-113
(-1.36%)		-64
(-0.78%)		-104
(-1.26%)		-158
(-1.9%)		-531
(-6.1%)		-105
(-1.27%)		+126
(+1.57%)		+3,970
(+94.37%)		-327
(-3.85%)		-
融券增減(張)
(增減幅)		+1
(+16.67%)		+1
(+16.67%)		+1
(+16.67%)		-15
(-68.18%)		-21
(-75%)		-18
(-72%)		-15
(-68.18%)		-6
(-46.15%)		-47
(-87.04%)		-
借券賣出增減(張)
(增減幅)		+194
(+2.73%)		+267
(+3.79%)		+525
(+7.74%)		-153
(-2.05%)		-137
(-1.84%)		-3,153
(-30.13%)		-2,541
(-25.79%)		+1,286
(+21.34%)		-1,958
(-21.12%)		0
(0%)
券資比增減+0.01+0.01+0.01-0.18-0.24-0.22-0.19-0.22-0.55-
項目：
輔助：
期別收盤漲跌漲跌
(%)		成交
(千張)		融資 (千張)融券 (千張)資券
互抵
(千張)		資券
當沖
(%)		券資
比
(%)		現股
當沖
(%)
買進賣出現償增減餘額使用
率％		買進賣出現償增減餘額使用
率％
26Q48.13-0.76-8.5532.22.212.130.05+0.048.184.590.020.010-0.020.01000.010.0922.8
26Q38.89+0.28+3.2553.32.712.690.56-0.548.144.570.020.040.01+0.020.020.010.010.010.2821.7
26Q28.61-2.49-22.4384.94.463.120.43+0.98.684.870.150.150000000.0219.6
26Q111.1-2.3-17.1620811.410.20.09+1.157.784.370.240.190-0.05000.040.020.0333.2
25Q413.4+4.7+54.0218411.38.30.63+2.356.633.720.330.370+0.040.050.020.10.050.7231.6
25Q38.7-0.52-5.6485.43.184.060.48-1.364.282.380.820.870.05+0.010.0100.10.120.2615.3
25Q29.22-1.38-13.0240.72.443.610.45-1.625.643.140.070.020-0.04000.030.080.0921.5
25Q110.6-0.85-7.4253.33.063.560.93-1.437.264.040.10.120+0.020.050.020.040.070.6924.1
24Q411.45-3.5-23.4171.24.23.960.14+0.118.694.840.080.10+0.030.030.010.050.080.3514.2
24Q314.95-0.2-1.3284.15.755.520.32-0.098.584.780.130.120-0.01000.020.020.0514.6
24Q215.15-0.3-1.941661112.70.29-28.674.830.120.130+0.010.0100.050.030.1520.8
24Q115.45+0.25+1.64798.335.460.42+2.4510.75.940.010.0100000.010.010.0113.6
23Q415.2+0.75+5.1912112.411.70.3+0.428.264.60.170.180+0000.090.070.0226.5
23Q314.45-3.4-19.051057.8410.80.22-3.197.844.370.160.040-0.12000.020.02023.5
23Q217.85+2.85+1914013.110.11.06+1.95116.150.180.30+0.120.120.060.070.051.1126.3
23Q115-1.05-6.5480.99.647.90.2+1.549.085.060.140.070-0.07000.050.070.0620.9
22Q416.05+0.8+5.2518212.912.30.39+0.197.544.21.061.30.2+0.040.080.040.090.051.0239.4
22Q315.25-1.75-10.2946731.930.30.14+1.57.354.11.941.940-0.010.040.020.550.120.541.1
期別收盤漲跌漲跌
(%)		成交
(千張)		融資 (千張)融券 (千張)資券
互抵
(千張)		資券
當沖
(%)		券資
比
(%)		現股
當沖
(%)
買進賣出現償增減餘額使用
率％		買進賣出現償增減餘額使用
率％
22Q2170019112.911.40.6+0.945.853.260.390.430+0.040.040.020.160.080.7435.8
22Q117+1.6+10.3914510.68.650.32+1.594.912.730.110.10-0.01000.060.04027.7
21Q415.4-1.9-10.9871.24.32.670.24+1.43.321.850.070.070+0.010.0100.010.010.2115.8
21Q317.3-1.65-8.7185.61.080.881.29-1.11.931.070.010.010+000000.0513.8
21Q218.95-6.35-25.116700.80.29-1.083.030000000000
21Q125.3+2.45+10.7216101.811.26-3.074.1100.1700-0.1700000
20Q422.85+1+4.5817402.80.39-3.197.2300.0200-0.020.170002.34
20Q321.85-3.1-12.4270060.960.22.13-1.3710.408.067.670.21-0.60.19019.92.851.8450.3
20Q224.95+13.6+119.8242543.338.90.9+3.5311.86.572.553.330.02+0.760.80.444.471.056.7438.5
20Q111.35-7.05-38.322663134.81.43-5.258.264.65.785.730.23-0.290.040.010.870.330.4231.3
19Q418.4+1.1+6.3614923.919.50.47+3.9913.57.530.741.050+0.30.320.170.650.432.3823.7
19Q317.3+0.15+0.8747.86.645.450.4+0.799.525.310.090.090+00.020.010.030.070.2222.8
19Q217.15-0.4-2.2853.39.067.520.21+1.338.734.870.160.160+00.0200.060.120.1917.5
19Q117.55+0.55+3.2432.63.93.790.06+0.057.44.130.050.040-0.010.0200.080.250.218.4
18Q417-3.45-16.8759.29.027.70.02+1.37.364.10.370.330-0.040.020.010.080.140.3420.2
18Q320.45-0.9-4.2243.47.083.870.01+3.26.063.380.070.130+0.050.070.030.050.111.1419.3
18Q221.35-2.4-10.1192.86.343.420.06+2.862.861.590.050.060+0.020.0200.020.020.5221.9
18Q123.75+2.05+9.4590.7
期別收盤漲跌漲跌
(%)		成交
(千張)		融資 (千張)融券 (千張)資券
互抵
(千張)		資券
當沖
(%)		券資
比
(%)		現股
當沖
(%)
買進賣出現償增減餘額使用
率％		買進賣出現償增減餘額使用
率％
17Q421.7+0.75+3.5838
17Q320.95-2.5-10.6645
17Q223.45-2.85-10.8445.6
17Q126.3-0.9-3.3130.7
16Q427.2-1.95-6.6956.8
16Q329.15+0.65+2.28119
16Q228.5+0.65+2.3384.8
16Q127.85-6.05-17.8588.1
15Q433.9+5.7+20.21187
15Q328.2+1.9+7.2268.614.1
15Q226.3-7.6-22.4253.710.7
15Q133.9-4.75-12.2935.37.23
14Q438.65-5.55-12.5660.612.6
14Q344.2-7.3-14.1713312.4
14Q251.5-3.3-6.0213510.2
14Q154.8+4.8+9.622911.5